entertainment -WSS

entertainment

author：leisure time 2025-10-02 00:43:28 - browse：58

Biogen, a biotech giant plagued by years of boardroom strife, said late Monday that the longtime and polarizing director Alex Denner would step down from its board, sending a signal to investors that the company’s fractious recent history might be coming to a close.

What Biogen didn’t disclose is that its nominee to replace Denner on the board, Susan Langer, is Denner’s live-in romantic partner and the mother of his child, born in November, according to court records obtained by STAT. Denner is in the middle of a protracted divorce from his wife of nearly 25 years, with whom he has two teenage sons — a bitter legal fight in which his extramarital relationship with Langer is a contentious issue, according to the records.

Biogen spokesperson Jack Cox said the company knew about the relationship between Denner and Langer. He also said that Denner recommended Langer to Biogen’s board — he said he incorrectly stated at first that Denner nominated her — but declined to comment on the company’s vetting process and whether it planned to disclose the relationship to shareholders before they vote on Langer’s candidacy later this month. Biogen also omitted mention of the relationship from Langer’s biography in a Securities and Exchange Commission filing Tuesday morning.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Involuntary treatment for addiction doesn't work

WSS

Argenx drug significantly slows progression of nerve disorder

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Abridge raises $150m as clinical notes automation market heats up

Celiac disease study examines precisely how gluten triggers injury

Europe sees delivery challenges ahead on Alzheimer's therapies

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

knowledge

entertainment

explore

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Cancer drug shortages should be causing more outrage

Global childhood vaccinations edge closer to pre

23andMe had bad news about my health. I wish a person had delivered it

Medicare Advantage enrollment grows 7.1% to 33.4 million people

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

In 'major milestone,' FDA approves first cell therapy for solid tumors

Alkermes shareholders re

Celiac disease study examines precisely how gluten triggers injury

explore

Opioid cravings were reduced by anti

Medicare Advantage enrollment hits roughly 33.4 million

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Abridge raises $150m as clinical notes automation market heats up

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Flagship Pioneering startup Sonata Therapeutics lays off 21

hotspot

focus

explore

entertainment